MedPath

Effectiveness of EMDR for adolescents with Major Depressive Disorder

Not Applicable
Completed
Conditions
<p>Major Depressive Disorder</p>
10012375
Registration Number
NL-OMON28950
Lead Sponsor
GGZ Rivierduinen
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
64
Inclusion Criteria

(a) age 12-18 years (b) Major Depressive Disorder (MDD) as primary classification (DSM-5) (c) identified memories of at least one distressing or traumatic event related to the depressive symptomatology

Exclusion Criteria

(a) suicidal attempt or serious non-suicidal self-injury requiring hospitalization in the past month (b) substance dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main parameter will be the effect of EMDR treatment on depressive symptomatology. Depressive symptoms will be measured by the CDI-2 and K-SADS-PL-5.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary parameters focus on the effect of EMDR treatment on comorbid PTSD, anxiety, somatic symptoms and overall social-emotional problems, measured by CATS, SCARED and SDQ. We will examine whether baseline posttraumatic stress symptoms severity, family functioning (measured by the FAD) and having experienced emotional abuse or neglect (CTQ) significantly predicts post-treatment outcome.</p><br>
© Copyright 2025. All Rights Reserved by MedPath